-
Not just genetic: 24-year-old dies of DEMENTIA, prompting research into environmental causes
14 Jan 2026 02:46 GMT
… that conveniently ignores the toxins, genetic manipulations, and environmental assaults … , often propelled by powerful genetic mutations that disrupt fundamental cellular … at in research on genetic transfer from modified crops, introduces unknown variables …
-
MA biotech company Tessera Therapeutics to lay off dozens of employees
13 Jan 2026 10:54 GMT
… .m. ET
A Somerville-based biotechnology company will lay off more … to utilize transformative genetic medicines to cure diseases and modify inherited risk … Pioneering in 2018, is a biotechnology company developing technology to …
-
In India’s unique health needs, biotech steps in with new treatment arsenal
13 Jan 2026 10:05 GMT
… body’s genetic code, drugmakers around the world are leveraging biotech breakthroughs … , the inaugural edition of ETPharma Biotech Leadership Symposium convened a panel … long been dominated by disease-modifying therapies. Whereas newer innovations like …
-
n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases
12 Jan 2026 19:04 GMT
… -focused pathways for individualized genetic medicines and to reducing … are short strands of modified DNA that can specifically … for rare diseases. Combining biotech agility with a mission- … -aso-therapies-for-rare-genetic-diseases-302658829.html
SOURCE …
-
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
12 Jan 2026 14:15 GMT
… therapies for ultra-rare genetic diseases. Under the proposed … and clinical researchers resolve genetically complex problems. Our products … are short strands of modified DNA that can specifically … for rare diseases. Combining biotech agility with a mission- …
-
Aptean and CAS Expand Collaboration with Biosequence Chemical Modifications Solution
12 Jan 2026 11:28 GMT
… collaboration designed to help biotech intellectual property researchers assess … expertise delivers a new Chemical Modifications module featuring Aptean GenomeQuest… pertinent patents across diverse biological modification patterns. “By combining our …
-
Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy
12 Jan 2026 11:30 GMT
… (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for … The publication, A novel modifier gene therapy to treat Stargardt … approaches, to an agnostic modification strategy that can potentially … type 1 is a genetic eye disorder caused by …
-
First leukaemia patient to receive pioneering treatment on NHS says it is 'very sci-fi'
14 Jan 2026 00:32 GMT
… immune cells, which had been genetically modified to recognise and target his … harmless virus to introduce a genetic sequence that enables them to …
-
Health News | Injection Turns Sleeping Tumour Immune Cells into Cancer Fighters: Study
14 Jan 2026 00:16 GMT
… lab-based cell extraction and modification. In animal models, the strategy … them in the lab, and genetically modifying them before reinfusion. This process … inside the body rather than modifying them outside it.
Their approach …
-
Monarch Legacy of Monsters Season 2 trailer: Netizens pumped by new monster
14 Jan 2026 00:19 GMT
… the creature is Biollante, a genetically-modified kaiju hybrid created from Godzilla …